• Aucun résultat trouvé

Pharmacological management of type 2 diabetes: what's new in 2017?

N/A
N/A
Protected

Academic year: 2021

Partager "Pharmacological management of type 2 diabetes: what's new in 2017?"

Copied!
36
0
0

Texte intégral

Loading

Figure

Table 1 : Cardiovascular outcome trials comparing a DPP-4 inhibitor with a placebo. Results are expressed by hazard ratio (with 95% confidence intervals)
Table 2 : Cardiovascular outcome trials with GLP-1 receptor agonists. Results are expressed by hazard ratio (with 95% confidence intervals)
Table 3 : Cardiovascular outcome trials with SGLT2 inhibitors. Results are expressed by hazard ratio (with 95% confidence intervals)
Table 4 : Adverse events reported with new glucose-lowering agents

Références

Documents relatifs

It is important to stress that those interaortocaval lymph nodes (right paraaortic lymph nodes—LN16) for pancreatic cancer of the head and celiac trunk lymph nodes (LN9) for tumors

Objectives: 1 Consider the critical standards for postgraduate family medicine education 2 Compare and contrast these standards with those developed in Canada 3 Discuss development

Learning spatiotemporal piecewise- geodesic trajectories from longitudinal manifold-valued data.. Neural Information Processing Systems 2017, Dec 2017, Long Beach, CA,

Increased mortality risk associated with LEA has been reported previously in people with diabetes [10, 21], but to the best of our knowledge, this is the first study that

We suggest that renal biopsies should be performed in diabetic patients with a sudden onset of renal failure, proteinuria without retinopathy, or other evidence of

The main findings of the present study are: 1) higher PP, PP/MBP, PPxHR and SBPxHR levels in middle-aged patients with type 1 diabetes compared with lean controls, in agreement

Pour répondre à ces questions de nombreuses analyses thermochronologiques basse- température (U-Th)/He ainsi que traces de fission ont été réalisées afin de

In this section we shall exploit the properties of b p,2 ν (Ω) to obtain new (and sharp) results for the Bergman spaces A p,2.. ν (T